Relmada Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (22)

View All

Latest Posts

About This Stock More About This Stock
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Article By: Moon Kil Woong
Friday, January 8, 2021 11:59 AM EDT
VistaGen’s deal with Pherin Pharmaceuticals to develop PH-94B has positioned the Company to grab a healthy share of, social anxiety, and major depression markets.
In this article: JNJ, SAGE, CNSP, AXSM, RLMD, VTGN
Read
An Interview With Relmada Therapeutics
Article By: Jason Napodano
Thursday, October 13, 2016 12:39 PM EDT
This is a transcript of an interview I did with the management team at Relmada Therapeutics.
In this article: RLMD Also: AGN, JNJ
Read
Relmada Therapeutics Launches Pharmaceutical Armada Against Chronic Pain And Opioid Abuse
Article By: The Life Sciences Report
Tuesday, April 26, 2016 5:06 PM EDT
Relmada's Therapeutics Inc. Michael Becker describes the company's programs, which are advancing steadily toward the marketplace.
In this article: RLMD Also: AGN, ENDP, BDSI
Read
All Posts

Latest Tweets for $RLMD

No tweets yet!

PARTNER HEADLINES